Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 44, Issue 2, 2005, Pages 138-141

  Rubnitz, Jeffrey E ^a   Hijiya, Nobuko ^b   Zhou, Yinmei ^b   Hancock, Michaell L ^b   Rivera, Gaston K ^b   Pui, Ching Hon ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

Acute lymphoblastic leukemia; Early detection; Relapse

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD CELL COUNT; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INFANT; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 11144296309     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20166     Document Type: Article

References (17)

1. Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-615.
2. Pui CH, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. J Am Med Assoc 2003;290:2001-2007.
3. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95:3310-3322.
4. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. Blood 2001;97:1211-1218.
5. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000;14:2223-2233.
6. Henze G, Fengler R, Hartmann R, et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991;78:1166-1172.
7. Henze G, von Stackelberg A. Treatment of relapsed acute lymphoblastic leukemia. In: Pui C-H, editor. Treat of acute leukemias: New directions for clinical research. Totowa, NJ: Humana Press, Inc; 2002. pp 199-219.
8. Chessells JM, Veys P, Kempski H, et al. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia. Br J Haematol 2003;123:396-405.
9. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy Studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000;14:2286-2294.
10. Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998;92:411-415.
11. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1999;53:457-481.
12. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-748.
13. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34: 187-220.
14. Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: Impact of site and time to first relapse-The Children's Cancer Group Experience. Cancer 1998;82:1387-1395.
15. Gandhi M, Rao K, Chua S, et al. Routine blood counts in children with acute lymphoblastic leukaemia after completion of therapy: Are they necessary? Br J Haematol 2003;122:451-453.
16. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Am Med Assoc 2003;290:1583-1592.
17. Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003;349:640-649.